The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency

The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency
复制标题

DOI:
10.22088/cjim.10.2.125
复制
发表时间:
2019-01-01
影响因子:
1.4
通讯作者:
Eslami, Bita
Eslami, Bita
中科院分区:
其他
文献类型:
--
作者:
Hajhashemi, Maryam;Ansari, Maryam;Eslami, Bita

文献摘要

被引文献

相似文献

背景资料:子宫平滑肌瘤(肌瘤)是育龄妇女中最常见的良性盆腔肿瘤,发病率为5.4%至77%。此外,伊朗维生素D缺乏症的患病率很高,有大量关于维生素D与子宫平滑肌瘤关系的体内和体外生物学研究。本研究的目的是评估维生素D补充剂对子宫平滑肌瘤的大小在妇女维生素D deficiency.Methods:这双盲前瞻性临床试验进行了69例子宫平滑肌瘤谁有维生素D缺乏症。A组(n=35)给予维生素D 50,000 IU,每2周1次,共10周; B组(n=34)给予安慰剂。结果:干预10周后,维生素D治疗组的25-羟维生素D-3水平显著高于对照组(36.08 vs 16.25 ng/ml)。与安慰剂组相比,维生素D组子宫肌瘤体积明显缩小(52.58vs61.11mm,P< 0.001)。维生素D是治疗子宫肌瘤的有效方法。
Background: Uterine leiomyomas (fibroids) are the most common benign pelvic tumors in women of reproductive age with an incidence ranging from 5.4% to 77%, Also, there is a high prevalence of vit D deficiency in Iran and there are the numbers of in vivo and vitro biological studies on the relationship of vitamin D and uterine leiomyomas. The aim of this study was to evaluate the effect of vit D supplementation on the size of uterine leiomyoma in women with vit D deficiency.Methods: This double-blind prospective clinical trial was performed on 69 patients with uterine leiomyomas who had vit D deficiency. Group A (n=35) was treated with vit D 50,000 IU every 2 weeks for 10 weeks, while group B (n=34) received placebo with same color and shape. Finally, the leiomyoma size in both groups was compared (IRCT: 20160521027998N5).Results: After a 10-week intervention, 25-hydroxyvitamin D-3 levels were significantly higher in group receiving vitamin D (36.08 vs 16.25 ng/ml). (P< 0.001) Leiomyomas size in vit D group significantly decreased as compared to placebo group (52.58 vs 61.11 mm, respectively).Conclusion: Our results showed that administration of vit D3 may reduce the size of leiomyoma. It seems that vitamin D administration is the effective way to treat leiomyoma.